Ligand validation:3VMA

M0E: MOENOMYCIN

M0E is a Ligand Of Interest in 3VMA designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VMA_M0E_A_901	41%	8%	0.142	0.908	1.99	2.64	21	53	5	0	71%	0.7064
3FWL_M0E_A_901	38%	39%	0.113	0.866	1.04	1.33	3	15	8	0	71%	0.7064
5HLB_M0E_A_901	26%	2%	0.161	0.854	3.19	3.54	37	54	7	0	71%	0.7064
5HL9_M0E_A_902	14%	2%	0.221	0.829	4.05	2.99	39	21	4	0	71%	0.7064
6YN0_M0E_A_901	11%	17%	0.194	0.767	2.26	1.37	23	10	0	0	71%	0.7064
5FGZ_M0E_A_901	9%	42%	0.246	0.793	0.91	1.34	5	11	7	0	71%	0.7064
3HZS_M0E_A_901	75%	22%	0.093	0.94	1.4	1.8	11	22	2	4	92%	0.9174
6FTB_M0E_A_301	47%	84%	0.154	0.891	0.2	0.56	-	3	12	0	100%	0.9478
3VMR_M0E_A_901	15%	4%	0.236	0.84	2.89	2.96	33	69	11	0	77%	0.7706

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.